Condition
mRNA Vaccine clinical trials and research
As of November 12, 2026, Find a Trial lists 5 mRNA Vaccine clinical trials that are recruiting, in China. By phase: Phase 1 (4), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest mRNA Vaccine clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| NeoOVSV mRNA Vaccine for ovarian cancer after surgery | Phase 1 | Chengdu, Sichuan | Recruiting | Jul 23, 2026 |
| NeoOVIV: a personalized mRNA vaccine plus standard therapy after ovarian cancer surgery | Phase 1 | Chengdu, Sichuan | Recruiting | Jun 30, 2026 |
| IL-22BP mRNA peptide therapy for advanced solid tumors | Phase 1 | Chengdu, Sichuan | Recruiting | May 13, 2026 |
| Lyophilized shingles mRNA vaccine safety and immune response | Phase 1/2 | Xinjiang | Recruiting | Feb 10, 2026 |
| IL-22BP mRNA vaccine for refractory advanced solid tumors | Phase 1 | Chengdu, Sichuan | Recruiting | Aug 3, 2025 |
All recruiting trials (5)
-
NeoOVSV mRNA Vaccine for ovarian cancer after surgery
We’re testing a novel mRNA vaccine added to standard therapy to see if it’s safe and can help patients with stage II/III ovarian cancer after surgery.
-
NeoOVIV: a personalized mRNA vaccine plus standard therapy after ovarian cancer surgery
A one-arm study tests a personalized mRNA vaccine (NeoOVIV) given with standard chemotherapy and a PD-1 blocker to see if it is safe and can trigger an immune response in women with stage II/III ovarian cancer after surgery.
-
IL-22BP mRNA peptide therapy for advanced solid tumors
A phase 1 study tests a new peptide-delivered IL-22BP mRNA treatment to see if it is safe and if it has any early signs of shrinking or stopping advanced solid tumors in adults.
-
Lyophilized shingles mRNA vaccine safety and immune response
This trial will test a lyophilized mRNA vaccine to see if it is safe and produces immune responses in adults aged 40 years and older.
-
IL-22BP mRNA vaccine for refractory advanced solid tumors
This trial will test an IL-22BP mRNA vaccine in lipid nanoparticles to see if it is safe and can slow or shrink advanced solid tumors in adults who have failed standard second-line treatments.
Related topics
Quick answers
How many mRNA Vaccine clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.